![logo](/logos/CPRX.webp)
Catalyst Pharmaceuticals, Inc.
NASDAQ:CPRX
19.6 (USD) • At close September 6, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 398.204 | 214.203 | 140.833 | 119.073 | 102.306 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.489 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of Revenue
| 84.532 | 34.393 | 21.884 | 17.039 | 14.759 | 19.919 | 0.046 | 0.043 | 0.034 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit
| 313.672 | 179.81 | 118.949 | 102.034 | 87.547 | -19.419 | -0.046 | -0.043 | -0.034 | 0 | 0 | 0 | 0 | 0.489 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross Profit Ratio
| 0.788 | 0.839 | 0.845 | 0.857 | 0.856 | -38.838 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Reseach & Development Expenses
| 93.15 | 19.789 | 16.936 | 16.497 | 18.843 | 19.919 | 11.375 | 11.37 | 11.801 | 10.118 | 8.097 | 2.66 | 3.384 | 2.307 | 5.097 | 8.71 | 2.991 | 0.989 | 1.463 | 0.378 | 0 | 0.138 |
General & Administrative Expenses
| 47.021 | 28.714 | 23.477 | 20.667 | 33.581 | 15.876 | 7.304 | 7.91 | 8.597 | 4.474 | 2.215 | 2.562 | 2.698 | 2.206 | 2.178 | 2.184 | 0 | 0 | 0 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 86.689 | 29.469 | 26.151 | 23.567 | 3.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SG&A
| 133.71 | 58.183 | 49.628 | 44.234 | 36.881 | 15.876 | 7.304 | 7.91 | 8.597 | 4.474 | 2.215 | 2.562 | 2.698 | 2.206 | 2.178 | 2.184 | 2.036 | 1.913 | 0.359 | 0.165 | 0 | 0 |
Other Expenses
| 7.699 | 2.881 | 0.282 | 0.587 | 1.586 | 1.292 | 0.454 | 0.322 | 0.1 | 0.076 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.429 | 0.118 |
Operating Expenses
| 226.86 | 77.972 | 66.564 | 60.73 | 55.724 | 35.795 | 18.68 | 19.28 | 20.398 | 14.591 | 10.312 | 5.221 | 6.082 | 4.513 | 7.275 | 10.894 | 5.027 | 2.902 | 1.822 | 0.543 | -0.429 | 0.256 |
Operating Income
| 86.812 | 101.838 | 52.385 | 41.303 | 31.823 | -35.295 | -18.68 | -19.28 | -20.398 | -14.591 | -10.312 | -5.221 | -6.082 | -4.024 | -7.275 | -10.894 | -5.027 | -2.902 | -1.822 | -0.543 | -0.429 | -0.256 |
Operating Income Ratio
| 0.218 | 0.475 | 0.372 | 0.347 | 0.311 | -70.59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.23 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Other Income Expenses Net
| 7.699 | 2.881 | 0.282 | 0.587 | 1.586 | 1.292 | 0.267 | 1.208 | 0.165 | -0.918 | -1.89 | 1.13 | -0.32 | 0.018 | 0.033 | 0.329 | 0.888 | 0.173 | 0.017 | 0.003 | 0 | 0 |
Income Before Tax
| 94.511 | 104.719 | 52.667 | 41.89 | 33.409 | -34.004 | -18.412 | -18.072 | -20.233 | -15.509 | -12.155 | -4.076 | -6.391 | -4.006 | -7.242 | -10.565 | -4.139 | -2.729 | -1.805 | -0.54 | 0 | -0.256 |
Income Before Tax Ratio
| 0.237 | 0.489 | 0.374 | 0.352 | 0.327 | -68.007 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.194 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Income Tax Expense
| 23.101 | 21.64 | 13.185 | -33.093 | 1.534 | 2.583 | 0.141 | -0.93 | -0.099 | 0.994 | 1.843 | -1.156 | 0.309 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.429 | 0 |
Net Income
| 71.41 | 83.079 | 39.482 | 74.983 | 31.875 | -34.004 | -18.412 | -18.072 | -20.233 | -15.509 | -12.155 | -4.076 | -6.391 | -4.006 | -7.242 | -10.565 | -4.139 | -2.729 | -1.805 | -0.54 | -0.429 | -0.256 |
Net Income Ratio
| 0.179 | 0.388 | 0.28 | 0.63 | 0.312 | -68.007 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.194 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS
| 0.67 | 0.8 | 0.38 | 0.72 | 0.31 | -0.33 | -0.21 | -0.22 | -0.25 | -0.24 | -0.27 | -0.14 | -0.29 | -0.22 | -0.48 | -0.81 | -0.33 | -0.36 | -0.29 | -0.18 | -0.15 | -0.11 |
EPS Diluted
| 0.63 | 0.75 | 0.37 | 0.71 | 0.3 | -0.33 | -0.21 | -0.22 | -0.25 | -0.24 | -0.27 | -0.14 | -0.29 | -0.22 | -0.48 | -0.81 | -0.33 | -0.36 | -0.29 | -0.18 | -0.15 | -0.11 |
EBITDA
| 119.955 | 101.838 | 52.385 | 41.303 | 31.823 | -35.295 | -18.493 | -20.166 | -20.463 | -13.571 | -8.399 | -6.351 | -5.719 | -3.998 | -7.245 | -10.861 | -5.011 | -2.897 | -1.821 | -0.543 | -0.429 | -0.256 |
EBITDA Ratio
| 0.301 | 0.475 | 0.372 | 0.347 | 0.311 | -70.59 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.177 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |